TY - JOUR
T1 - 麻豆直播app EV-104: Phase 1 study of intravesical enfortumab vedotin for treatment of patients with non-muscle invasive bladder cancer (NMIBC)鈥擳rial in progress.
JO - Journal of Clinical Oncology
UR - http://dx.doi.org/10.1200/jco.2023.41.6_suppl.tps582
PY - 2023/02/20
AU - Kamat AM
AU - Steinberg GD
AU - Inman BA
AU - Kates MR
AU - Uchio EM
AU - Porten SP
AU - Roupret M
AU - Redorta J
AU - Catto JWF
AU - Kulkarni GS
AU - Powles T et al
ED -
DO - DOI: 10.1200/jco.2023.41.6_suppl.tps582
PB - American Society of Clinical Oncology (ASCO)
VL - 41
IS - 6_suppl
SP - TPS582
EP - TPS582
Y2 - 2025/07/29
ER -